I recall more than just one patent being granted around assays. The earlier one(s) some months ago posted by Wilma perhaps.
The patents are the moat and despite your disparaging remarks about some of us posters we have been aware of the billion(s) dollar value of this moat the whole time. What do you think is behind the claims of 100x growth in share price over time of left alone?
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-507
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $6.040M | 3.735M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 12184 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 7147 | 13 |
View Market Depth
| Last trade - 15.08pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |